Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Partnership with National Kidney Foundation

December 2, 2020
RNS Number : 3041H Renalytix AI PLC 02 December 2020   Renalytix AI plc (" RenalytixAI " or the " Company ")   Partnership with National Kidney Foundation   to improve management of Early Stage Kidney Disease   Program focused on improving disease management and outcomes beginning at the primary

Holding(s) in Company

November 26, 2020
RNS Number : 5461G Renalytix AI PLC 26 November 2020   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS   (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing

Second Price Monitoring Extn

November 25, 2020
RNS Number : 5327G Renalytix AI PLC 25 November 2020   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension

Price Monitoring Extension

November 25, 2020
RNS Number : 5304G Renalytix AI PLC 25 November 2020   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders

Financial Results for First Quarter of FY 2021

November 25, 2020
RNS Number : 3896G Renalytix AI PLC 25 November 2020     Renalytix AI plc ("RenalytixAI" or the "Company")   RenalytixAI Reports Financial Results for First Quarter of Fiscal Year 2021   NEW YORK , November 25, 2020   - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial

RenalytixAI to Participate in the Stifel 2020 Healthcare Conference

November 13, 2020
NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today announced the

Stifel 2020 Healthcare Conference

November 13, 2020
RNS Number : 1993F Renalytix AI PLC 13 November 2020     Renalytix AI plc (" RenalytixAI " or the " Company ")   RenalytixAI to Participate in the Stifel 2020 Healthcare Conference   NEW YORK , November 13, 2020   - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled

Change of Adviser

November 6, 2020
RNS Number : 4449E Renalytix AI PLC 06 November 2020       Renalytix AI plc (" RenalytixAI " or the " Company ")   Change of adviser   NEW YORK , November 6, 2020    - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on
Displaying 11 - 20 of 152